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Abstract
Chlamydia trachomatis is the main cause of sexually transmitted diseases worldwide. As
obligate intracellular bacteria Chlamydia replicate in a membrane bound vacuole called
inclusion and acquire nutrients for growth and replication from their host cells. However,
like all intracellular bacteria, Chlamydia have to prevent eradication by the host's cell
autonomous system. The chlamydial deubiquitinase Cdu1 is secreted into the inclusion
membrane, facing the host cell cytosol where it deubiquitinates cellular proteins. Here
we show that inactivation of Cdu1 causes a growth defect of C. trachomatis in primary
cells. Moreover, ubiquitin and several autophagy receptors are recruited to the inclusion
membrane of Cdu1-deficient Chlamydia. Interestingly, the growth defect of cdu1
mutants is not rescued when autophagy is prevented. We find reduced recruitment of
Golgi vesicles to the inclusion of Cdu1 mutants indicating that vesicular trafficking is
altered in bacteria without active deubiquitinase (DUB). Our work elucidates an impor-
tant role of Cdu1 in the functional preservation of the chlamydial inclusion surface.
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1 | INTRODUCTION
Chlamydia trachomatis is an obligate intracellular human pathogen and
the most common transmitted sexually disease worldwide (Newman
et al., 2015). Infection with the pathogen can manifest in a spectrum
of diseases like ectopic pregnancy, infertility but also in the blinding
eye disease trachoma (Bartlett, Levison, & Munday, 2013; Bébéar &
de Barbeyrac, 2009; Wright, Turner, & Taylor, 2008). Chlamydia repli-
cate in a biphasic developmental cycle. Chlamydial elementary bodies
(EBs) infect epithelial cells via the endocytotic pathway and transform
into replicative reticulate bodies (RBs) within a vacuole, the chlamydial
inclusion (Engel, 2004). After several rounds of replication inside the
inclusion, RBs complete their life cycle and transform back into infec-
tious EBs which are released from the host cell via extrusion or cell
lysis (Hybiske & Stephens, 2007). Chlamydia secrete several effectors
into the host cell by the type III secretion system (Subtil et al., 2005;
Valdivia, 2008) to orchestrate their developmental cycle, receive host
cell metabolites and prevent damage or premature death of their host
cell. The natural ribbon-like Golgi architecture is destroyed in cells
infected with C. trachomatis and vesicular mini stacks originating from
fragmented Golgi closely associate with the chlamydial inclusion (Heuer
et al., 2009). Host cell sphingolipids are required for the intracellular
growth of C. trachomatis in epithelial cells, with sphingomyelin attained
via the intersection of the chlamydial inclusion with these Golgi-derived
vesicles (Hackstadt, Rockey, Heinzen, & Scidmore, 1996).
As all pathogenic bacteria, Chlamydia has to subvert the host's
immune system to establish a successful infection and both, the adap-
tive and the innate immune response are effective to control chlamydial
infections (Fischer & Rudel, 2016). The cell autonomous immune
defence present in all human cells is particularly relevant for an obligateDaniela Auer and Sophie D. Hügelschäffer contributed equally to this work.
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intracellular pathogen like Chlamydia (Fischer & Rudel, 2016). A very
efficient arm of cell autonomous defence is the removal of pathogens
via autophagy. Foreign particles like intracellular bacteria in the cytosol
or in vacuoles are specifically marked by ubiquitination. In eukaryotic
cells poly-ubiquitination of proteins via lysine 63 (K63) is mainly
involved in autophagic events like mitophagy or the removal of Salmo-
nella from the cytoplasma via xenophagy, a form of autophagy specifi-
cally targeting bacteria (Geisler et al., 2010; Van Wijk et al., 2012).
K48 poly-ubiquitination of proteins often serves as a signal for
proteasomal degradation (Hershko & Ciechanover, 1998; Vucic,
Dixit, & Wertz, 2011). Ubiquitination of any kind happens via a cas-
cade of several proteins (Kleiger & Mayor, 2014). This posttransla-
tional modification is tightly regulated but also reversible by removal
of the ubiquitin by deubiquitinating enzymes (DUBs).
Ubiquitination of the bacterial membrane or the surrounding vacu-
ole membrane then recruits autophagy adapter proteins to the ubiquitin
molecules (Kirkin, Lamark, Johansen, & Dikic, 2009; Svenning &
Johansen, 2013). As a consequence, ubiquitin bound adapters recruit
autophagy-related gene 8 (ATG8) family proteins like the light chain
3 (LC3) protein which mediate the formation of the autophagosome
around the intruder. Finally, autophagosomes fuse with lysosomes
resulting in the destruction of the engulfed bacteria in the formed
autolysosomes (Dikic, 2017).
However, bacteria have evolved strategies to interfere with the
autophagy system in order to stay alive and proliferate. In Salmonella
infection one third of all bacteria are targeted for lysosomal degradation
through xenophagy (Birmingham, Smith, Bakowski, Yoshimori, &
Brumell, 2006). This affects free Salmonella in the host cytosol as well as
bacteria engulfed in the Salmonella containing vacuole (SCV). The SCV
membrane often gets punctured which leads to the recruitment of the
autophagy system (Thurston, Wandel, von Muhlinen, Foeglein, & Ran-
dow, 2012). In order to prevent clearance Salmonella has evolved mech-
anisms to repair the damaged SCV (Kreibich et al., 2015). Moreover,
Salmonella secrete SopA into the cytosol, a HECT E3 ligase with yet
unknown targets (Zhang, Higashide, McCormick, Chen, & Zhou, 2006).
Also Legionella, E. coli and Shigella are known to secrete effector proteins
into the host cell that interfere with the ubiquitination system, often by
mimicking E3 ligases (Huibregtse & Rohde, 2014). Chlamydia has also
established mechanisms to evade autophagosomal degradation. Early
studies revealed that C. trachomatis inclusions do not fuse with
autophagosomes in human epithelial cells (Al-Younes, Brinkmann, &
Meyer, 2004). The adaptation of Chlamydia species to the host specific
autophagy system is a fascinating example of co-evolution. The mouse
pathogen C. muridarum was able to overcome autophagic defence in
mouse cells, whereas the human pathogen C. trachomatis was suscepti-
ble (Yasir, Pachikara, Bao, Pan, & Fan, 2011). In human epithelial cells, in
contrast, C. muridarum inclusions attracted several components of the
autophagy pathway. However, C. trachomatis inclusions were resistant
to ubiquitination, which prevented the association of the autophagy
adaptors p62 and nuclear dot protein 52 kDa (NDP52) and the
autophagosomal marker LC3 with the inclusion (Haldar et al., 2016).
Although the chlamydial factors mediating the evasion of host
autophagy remain unknown, Chlamydia appears to subvert host
autophagy by at least two mechanisms: (a) keeping the inclusion intact
(Weber et al., 2017b); and (b) interfering with initial ubiquitination of
the inclusion. The genome of C. trachomatis encodes for two
deubiquitinases ChlaDUB1 and ChlaDUB2, hereafter referred to as
Cdu1 and Cdu2 (Misaghi et al., 2006). We recently showed that Cdu1 is
secreted into the chlamydial inclusion facing with its active site to the
host cell cytoplasm where it interacts with the host cell proteome and
stabilises anti-apoptotic Mcl-1 through deubiquitination (Fischer
et al., 2017).
In this paper we show that Cdu1 is essential for normal develop-
ment in primary host cells. Inactivation of Cdu1 in Chlamydia resulted
in the recruitment of the autophagy machinery to and phagophore
formation at the chlamydial inclusion. Despite phagophore formation
at the cdu1 mutant inclusion, autophagy was not effective in interfer-
ing with chlamydial development. The lack of active Cdu1 prevents
Golgi vesicle recruitment and slows the transition of RB to EB
resulting in decreasing progeny.
2 | RESULTS
2.1 | Chlamydia require Cdu1 for growth in primary
cells
We previously demonstrated that a transposon insertion mutant of
cdu1 (Ctr Tn-cdu1) expressing truncated Cdu1 protein is attenuated in
a mouse infection model and in cell lines challenged with interferon-γ
(IFN-γ) (Fischer et al., 2017). In the absence of IFN-γ Ctr Tn-cdu1 grew
without significant difference in several tumour cell lines (Fischer
et al., 2017). Tumour cell lines are known to have altered cell autono-
mous defence including autophagy (Kimmelman, 2011). We therefore
asked whether primary cells permit the development of Ctr Tn-cdu1
like previously observed for tumour cells. Primary human fallopian
tube cells (Fimb) and human umbilical vein endothelial cells (HUVEC)
were infected with wild-type and mutant bacteria and the relative
infectivity was determined by transferring bacteria after 48 hr from
these primary infections to fresh cells (here referred to as infectivity
assay). Fimb and HUVEC infected with Ctr Tn-cdu1 produced less
infectious chlamydial particles compared to wild-type infected cells
(Figure 1a). In contrast, no deficiency in growth was detected in
tumour cell lines like HeLa under these conditions. A detailed analysis
of later infection time points revealed a delayed development of Ctr
Tn-cdu1 compared to wild-type bacteria (Figure 1b). Moreover, elec-
tron microscopy (EM) pictures revealed that Ctr Tn-cdu1 inclusions in
Fimb cells harbour less chlamydial particles 30 hr post infection than
wild-type Chlamydia (Figure 1c, d). The ratio of EBs in Ctr Tn-cdu1
infected cell was reduced compared to wild-type Chlamydia
(Figure 1d). Therefore, the transition of RB to EB seems to be stalled
in the mutant infection. The differentiation of RB to EB is not
completely understood, nevertheless, the size of RBs is discussed to
be important in this process (Lee et al., 2018). We measured the aver-
age size of RBs in chlamydial inclusions after 30 hr in Fimb cells and
found that RBs of wild-type Chlamydia were significantly smaller
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(0.5814 μm ± 0.056) than RBs of the bacteria lacking an active Cdu1
deubiquitinase (0.8236 μm ± 0.065) (Figure 1e). Thus, Chlamydia lac-
king active Cdu1 are developing slower, resulting in less infectious
EBs compared to the wild-type bacteria.
2.2 | Inclusions of Ctr Tn-cdu1 are ubiquitinated
Recently we showed that the deubiquitinase Cdu1 is secreted into
the inclusion membrane with the active site located on the host cell
F IGURE 1 Inactive Cdu1 results in reduced bacterial growth in primary cells. (a) Primary HUVEC and Fimb and HeLa cells were infected with
CtrWT (wild-type) or Ctr Tn-cdu1 at a multiplicity of infection (MOI) of 0.3 for primary cells and a MOI of 1 for HeLa cells. Lysates of primary
infected cells were prepared after 24 hr. For progeny infection lysates were taken 48 hpi and used to infect fresh cells (see Experimental
procedures for details). Twenty four hours later, lysates of these cells were investigated by Western blotting. Shown is the relative amount of
chlamydial HSP60 (cHSP60) or OmpA. Protein loading was normalised to actin. Significance was calculated with the Student's t test. *p < .05,
HeLa, HUVEC n = 3, Fimb n = 4. (b) Fimb and HeLa cells were infected with CtrWT or Ctr Tn-cdu1 at MOI 0.3 and MOI 1 respectively. At
indicated time points post infection, infected cells were lysed and the supernatant was used to infect fresh cells. Twenty four hours later, cells
were lysed in sodium dodecyl sulfate (SDS)-sample buffer and chlamydial load was determined by immunoblot for OmpA. GAPDH was used as a
loading control. (c) Fimb cells were infected with CtrWT or Ctr Tn-cdu1 with a MOI of 0.3. 30 hpi cells were fixed and prepared for EM (see
Experimental procedures for details). Scale bar, 1 μm. (d) Quantification of bacterial particles, reticulate bodies (RBs) and elementary bodies (EBs)
in Fimb cells infected with CtrWT or Ctr Tn-cdu1 for 24 hr using EM pictures. Infection and samples preparation for EM was done as described in
(b). Bacterial particles of 22 inclusions were analysed. (e) Fimb cells were infected with CtrWT or Ctr Tn-cdu1MOI 0.3 for 30 hr. Cells were fixed
and prepared for EM. Transmission electron microscopy pictures were taken and RB diameter from five inclusions for each sample was measured.
Significance was calculated with the Student's t test. ** p < .01
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F IGURE 2 Ctr Tn-cdu1 inclusion is ubiquitinated. HeLa (a) or Fimb cells (b) were infected with CtrWT or Ctr Tn-cdu1 for 24 hr at a MOI of
1 or 0.3 respectively. Cells were fixed with 4% paraformaldehyde (PFA)/sucrose followed by indirect immunofluorescence. Chlamydial HSP60
(pink) as well as K48-linked ubiquitin (green, left panel) or K63-linked ubiquitin (green, right panel) was detected. Scale bar, 10 μm. (c) Hela
Cdu1-Flag cells were infected with CtrWT or Ctr Tn-cdu1 at a MOI of 1 for 24 hr with/without addition of AHT (50 ng/ml) for 4 hr. Cells were
fixed with 4% PFA/sucrose and indirect immunofluorescence was performed with ubiquitin (green) and Cdu1 (pink). The asterisk shows the
chlamydial inclusion. Scale bar, 10 μm. (d) Quantification of (c) showing ubiquitination of CtrWT or Ctr Tn-cdu1 inclusions in HeLa Cdu1-Flag and
HeLa Cdu1(C345A)-Flag cells upon AHT treatment. Pictures shown in (c) from three independent experiments were used to count 100 inclusions
per replicate with and without ubiquitin signal around the chlamydial inclusion. ND, not detected. (e) HeLa cells were infected with CtrWT and
Ctr Tn-cdu1 at a MOI of 1 for 24 hr before cells were fixed using 4% PFA/sucrose. Indirect immunofluorescence was performed against Cdu1
(green), ubiquitin (pink) and 40 ,6-Diamidino-2-phenylindol (DAPI) for DNA (blue). Cell contours are marked in white. Scale bar, 10 μm
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F IGURE 3 Ubiquitinated inclusions of Ctr Tn-cdu1 are recognised by the host cell autophagy system. (a) HeLa cells were infected with Ctr
WT or Ctr Tn-cdu1 at a MOI of 1 for 24 hr. Cells were fixed with 4% PFA/sucrose and indirect immunofluorescence microscopy was performed
with K63 ubiquitin (green), p62/SQSTM1 (red) and DAPI for DNA. Scale bar, 10 μm. (b) HeLa cells were infected with the chlamydial strains Ctr
WT and Ctr Tn-cdu1 at a MOI of 1 for 24 hr followed by fixation with 4% PFA/sucrose. For indirect immunofluorescence microscopy cells were
stained for cHSP60 (green) and light chain 3 (LC3) (pink). Scale bar, 10 μm. (c) Immunofluorescence images of CtrWT and Ctr Tn-cdu1 infected
HeLa cells were analysed by counting inclusions positive for p62 or LC3 recruitment. 34 pictures of three independent experiments were
counted. Significance was calculated by Student's t test. * p < .05, ** p < .001. (d) HeLa cells were infected with CtrWT or Ctr Tn-cdu1 at a MOI
of 1 for the indicated time points. Cells were then lysed in SDS-sample buffer and expression of p62, LC3, cHSP60 and beta-Actin was detected
by immunoblot. (e) The levels of the indicated proteins from the immunoblots shown in panel (d) were quantified for the 24 hpi time point. Shown
are the mean from three independent experiments ±SD. Significance was tested using the Student's t test. * p ≤ .05, ** p ≤ .01. (f) Fimb cells
infected with CtrWT or Ctr Tn-cdu1 at a MOI of 0.3 for 30 hr were fixed for EM preparation. Representative images are shown. The white arrow
appoints to a double membrane forming around the chlamydial inclusion. Scale bar, 1 μm
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F IGURE 4 Growth and replication defect of Ctr Tn-cdu1 in primary cells is independent of autophagy. (a) HeLa cells were infected with Ctr
WT or Ctr Tn-cdu1 at a MOI of 1 for 24 hr before cells were fixed with 4% PFA/sucrose. Cells were stained for Lamp1 (green) and cHSP60 (pink).
Scale bar, 10 μm. (b) Primary Fimb cells were infected with CtrWT or Ctr Tn-cdu1 at a MOI of 0.3 for 24 hr and treated with or without 10 nM
Bafilomycin A1 for 7 hr. Cells were lysed in SDS-sample buffer and immunoblot was performed. (c) Relative growth of CtrWT and Ctr Tn-cdu1
after 24 hr in Fimb cells treated with or without Bafilomycin A1 for 7 hr. Bacterial load was determined by quantifying chlamydial OmpA levels
and normalisation to GAPDH (b). Significance was calculated using the Student's t test. * p < .05. (d) Fimb cells were treated with a control siRNA
(siControl) or sip62 for 24 hr before infection with CtrWT or Ctr Tn-cdu1 at a MOI of 0.3. Lysates were taken 24 hpi and analysed by
immunoblotting for p62, OmpA and actin. (e) Infectivity assay in PentaKO and Parental cells was performed. Cells were infected with CtrWT and
Ctr Tn-cdu1 with a MOI of 1 and lysates from these primary infections were taken 24 hpi (Primary). For progeny infection cells were lysed 48 hpi
and fresh HeLa cells were infected with the infections supernatant. Lysates for progeny infection were taken 24 hpi. Both, primary and progeny
infection were analysed for chlamydial load by immunoblotting for cHSP60. (f) Quantification of immunoblots showing relative bacterial growth
in PentaKO and Parental cells. Bacterial load was determined by quantifying chlamydial HSP60 (cHSP60) levels and normalisation to actin (e).
Growth of wild-type Chlamydia was set to 100%. Results of three independent experiments are shown. Significance was calculated using the
Student's t test. * p < .05, ** p < .01
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side (Fischer et al., 2017). We tested whether the inactive Cdu1 pro-
tein alters the ubiquitination pattern in the host cell. Indeed the inclu-
sion of Ctr Tn-cdu1 was decorated with K48 and K63 linked ubiquitin
chains in contrast to the wild-type strain that shows no ubiquitin sig-
nal (Figure 2a, b). Interestingly even though Ctr Tn-cdu1 grew nor-
mally in HeLa cells, inclusions were similarly ubiquitinated as in
primary Fimb cells in which the development of EBs was affected
(Figure 2a, b). To demonstrate that Cdu1 is responsible for the
removal of ubiquitin residues at the inclusion surface, cdu1 was
expressed under the control of a tetracycline-inducible promoter.
Addition of anhydrotetracycline (AHT), a potent inducer of the tetra-
cycline promoter, resulted in the expression of wild-type Cdu1 with-
out the membrane spanning domain in the HeLa Cdu1-Flag cell
cytoplasm and the removal of ubiquitin from the Ctr Tn-cdu1 inclusion
(Figure 2c, d). A similar effect was observed in primary Fimb upon
transfection of the pEGFP-N1/Cdu1 construct (Figure S2a). To dem-
onstrate that Cdu1 activity is required to remove ubiquitin from the
inclusion surface a HeLa cell line with an inactive Cdu1-Flag (Cdu1
(C345A)) was generated (HeLa Cdu1(C345A)-Flag) (Figure S1c) and
the same construct was transfected into primary Fimb cells. Induction
of Cdu1(C345A)-Flag failed to deubiquitinate inclusions in HeLa
(Figure 2d, S1a). Likewise, deubiquitination of the inclusion was not
observed upon transfection of Fimb cells with pEGFP-N1/Cdu1ΔCD
lacking the catalytic C-terminal domain (Figure S2b), demonstrating
that the Cdu1 deubiquitinase activity is required for the removal of
ubiquitin from chlamydial inclusions. We then asked if the Cdu1 activ-
ity to remove ubiquitin from Ctr Tn-cdu1 inclusions can also be pro-
vided by the wild-type bacteria in co-infection experiments.
Simultaneous infection of HeLa cells with Ctr WT and Ctr Tn-cdu1
revealed that active Cdu1 in the inclusion membrane cannot
deubiquitinate other inclusions in the same cell that are not in direct
proximity to the protease (Figure S3a). However, at sites of contact a
deubiquitination activity locally removes ubiquitin from the surface of
the mutant inclusion (Figure 2e, S3b). Interestingly, inclusion with
both, Cdu1 wild-type and mutant bacteria did not display ubiquitin on
the inclusion surface (Figure S3c) demonstrating that wild-type Chla-
mydia can complement the deubiquitination defect of Ctr Tn-cdu1
from inside the inclusion. We conclude from these results that the
chlamydial inclusion is constantly ubiquitinated in the absence of
Cdu1 and the high deubiquitinating activity of Cdu1 removes
ubiquitin from the surface of the inclusion.
2.3 | The autophagy machinery is recruited to the
ubiquitinated inclusion
Ubiquitination via lysine 48 is often a signal for protein degradation
by the proteasome, whereas a linkage via K63 preferably induces
autophagy (Hershko & Ciechanover, 1998; Olzmann & Chin, 2008;
Vucic et al., 2011). Autophagy adapters like sequestosome1 (hereafter
referred to as p62) bind to ubiquitin K63 and subsequently recruit
autophagy initiation proteins like LC3. Compared to inclusions of
wild-type bacteria, inclusions of Ctr Tn-cdu1 contained high amounts
of p62 visible as surface-associated ring structures on these inclusions
(Figure 3a, c). Furthermore, p62 protein levels were upregulated in
cells infected with Ctr Tn-cdu1 starting around mid-phase of the
developmental cycle (Figure 3d, e). In addition to p62, the autophagy
receptors next to BRCA1 gene 1 protein (NBR1) and NDP52 were
also identified at the chlamydial inclusion of Ctr Tn-cdu1 infected
HeLa and Fimb cells (Figure S4 a–d). Autophagy cargo proteins like
p62 bind to ubiquitin and facilitate the recruitment of LC3 for phago-
phore formation. During Ctr Tn-cdu1 infection, levels of non-lipidated
LC3I and lipidated and active LC3II increased during the mid-stage of
the cycle (Figure 3d, e) and accumulation of all LC3 variants (LC3A,
F IGURE 5 Altered Golgi recruitment in Ctr Tn-cdu1 infected cells. (a) HeLa cells were left uninfected or were infected with CtrWT or Ctr Tn-
cdu1 at a MOI of 1 for 24 hr. For indirect immunofluorescence cells were fixed with 4% PFA/sucrose. Chlamydia were stained for cHSP60 (pink)
and the Golgi for GM130 (green). Scale bar, 10 μm. (b) Quantification of immunofluorescence pictures showing intact and compact Golgi,
fragmented and recruited or fragmented and dispersed Golgi in cells infected with CtrWT or Ctr Tn-cdu1. Phenotype of Golgi in infected cells
was determined and counted in immunofluorescence pictures obtained in (a). Three independent experiments were performed and approximately
100 cells were counted. Significance was calculated using the Student's t test. n.s. not significant, *p < .05, **p < .01
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LC3B, LC3C) (Figure S4 i–k) as well as the ATG8 family members
GABARAP, GABARAPL1 and GABARAPL2 (Figure S4 f–h) were
detected around the inclusion (Figure 3c, Figure S4 f–k) which indi-
cates the formation of an autophagophore that was observed for the
mutant but not the wild-type Chlamydia (Figure 3b, f). In addition the
lipidation of LC3I to form lipidated LC3II initiating autophagophore
formation depends on a multi-protein complex which also includes
ATG12. ATG12 was also identified at the inclusion of Ctr Tn-cdu1
(Figure S4e). These experiments confirmed the recruitment of
autophagy receptors to and the formation of a LC3 positive double
membrane around the inclusion of Ctr Tn-cdu1 during infection.
2.4 | The growth defect of Ctr Tn-cdu1 in primary
cells is independent of autophagy
Phagophore formation and recruitment of the autophagy machinery
to bacteria containing vacuoles are clear indications of active
xenophagy. We therefore tested whether autophagosomes forming
around the Ctr Tn-cdu1 inclusion fuse with lysosomes. However, co-
localization with the lysosomal marker protein Lamp1 could not be
observed (Figure 4a). As the autophagy system is recruited to the
inclusion we tested whether autophagy actively degrades the bacteria
which would explain the observed growth defect of the mutant in pri-
mary cells. The lysosomal inhibitor Bafilomycin A1 interferes with the
degradation of bacteria by inhibition of the H+-ATPase and prevention
of the acidification of the lysosomal lumen. To determine the bacterial
load upon inhibitor treatment, levels of bacterial OmpA or HSP60 pro-
tein were detected by immunoblotting. These assays revealed that
Bafilomycin A1 treatment could not rescue the growth defect in Ctr
Tn-cdu1 (Figure 4b, c). To further corroborate that reduced infectivity
of the mutant depends on autophagy we also targeted the early
stages of autophagy. Knock down of the key autophagy marker p62
in primary Fimb cells did not rescue the growth defect of Ctr Tn-cdu1
(Figure 4d). Several different autophagy receptors in addition to p62
were identified at the inclusion of Ctr Tn-cdu1 that could compensate
F IGURE 6 Altered Golgi
recruitment in Ctr Tn-cdu1 infected
cells can be rescued. (a) HeLa FlpIn
Cdu1Flag cells were infected with Ctr
WT or Ctr Tn-cdu1 at a MOI of 1 for
20 hr before 50 ng/ml AHT was
added for 4 hr. For indirect
immunofluorescence cells were fixed
with 4% PFA/sucrose. Chlamydia
were stained for cHSP60 (pink) and
the Golgi for GM130 (green). Scale
bar, 10 μm. (b) Quantification of
immunofluorescence pictures
showing fragmented recruited and
fragmented dispersed Golgi in Ctr
WT or Ctr Tn-cdu1 infected HeLa
cells. Phenotype of Golgi in infected
cells was determined and counted in
immunofluorescence pictures
obtained in (a). Three independent
experiments were performed and
approximately 100 cells were
counted. Significance was calculated
using the Student's t test. n.s. not
significant, *p < .05,
**p < .01, ***p < .001
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for reduced p62 levels. Therefore, a PentaKO cell line with deletions
in the autophagy markers p62, NBR1, NDP52, Optineurin and
TAX1BP1 was used to test the involvement of any known autophagy
marker (Lazarou et al., 2015). The PentaKO cell line as well as the
parental strain are also negative for Parkin E3 ligase. Knock out of all
these autophagy genes did not rescue the growth of Ctr Tn-cdu1 in
primary or progeny infection (Figure 4e, f). In line with previous results
we therefore claim that the growth defect of Ctr Tn-cdu1 is not due
to the autophagy and degradation by the lysosome but rather a
slowed replication and transition of chlamydial RBs to EBs.
2.5 | Altered Golgi fragmentation of Ctr Tn-cdu1
can be rescued
Reasons for impaired development in Chlamydia can be various. As obli-
gate intracellular bacteria Chlamydia are known to consume metabolites
and nutrients from the host cell. In wild-type Chlamydia infected cells
the Golgi is fragmented and recruited to the inclusion surface for
enhanced lipid acquisition by the bacteria (Heuer et al., 2009). In Ctr Tn-
cdu1 infected HeLa cells we find the Golgi also fragmented, however,
recruitment to the chlamydial inclusion is impaired and the fragmented
Golgi vesicle appeared dispersed around the inclusion (Figure 5a, b). To
demonstrate that this reduced Golgi vesicle recruitment is due to a
defect in Cdu1 activity in cells infected with mutant Chlamydia we
expressed active Cdu1 in the cytoplasm of the cell. In cells complemen-
ted with Cdu1 Golgi stacks were recruited to the Ctr Tn-cdu1 inclusion
as in wild-type infected cells (Figure 6a, b). Golgi fragmentation was
hardly visible in infected Fimb cells (Figure S5) suggesting that defects in
Golgi fragmentation do not account for the growth difference of wild-
type and mutant Chlamydia in these cells. Furthermore, acquisition of
ceramide appeared neither affected in HeLa nor in Fimb cells
(Figure S6), ruling out a defect in ceramide uptake as a reason for the
developmental defect of Ctr Tn-cdu1. All in all our data suggest that
Cdu1 is required for the efficient recruitment of Golgi vesicles to the
inclusion surface of Chlamydia, an effect that appears to be host cell
dependent and independent of ceramide uptake into the inclusion.
3 | DISCUSSION
Obligate intracellular bacteria like Chlamydia acquire metabolites from
the host cell, which is expected to induce nutrient stress and
autophagy. In addition, recent research into the role of autophagy as
cell autonomous defence against intracellular pathogens suggested that
autophagy not only defeats bacteria residing in the cytosol of the host
but also bacteria in membrane bound phagosomes if these are leaky
(Birmingham et al., 2006; Gomes & Dikic, 2014; Mitchell & Isberg,
2017). It was therefore an obvious assumption that autophagy may play
a role in restricting chlamydial infection either as a consequence of
nutrient stress or as cell autonomous defence. Our data suggest a com-
plex interaction of Chlamydia with cell autonomous defence mecha-
nisms restricting metabolite acquisition and autophagic destruction.
Although Chlamydia does not reside in the cytosol of host cells
for extended times, a leaky or perforated inclusion membrane during
late stage infections or as a consequence of cell autonomous immune
attack may offer targets for activating autophagy (Fischer & Rudel,
2018; Weber et al., 2017a). In Ctr Tn-cdu1, but not in wild-type
infected cells we find the inclusion decorated with ubiquitin and
recruitment of autophagy proteins already during the replicative
phase of the bacteria (24 hpi) when the inclusion is still intact (data
not shown). We therefore postulate that the chlamydial inclusion is
constantly targeted by the autophagy machinery but the chlamydial
deubiquitinase Cdu1 efficiently interferes with this process at the ini-
tial steps by removing ubiquitin from the inclusion surface. This role
of Cdu1 is supported by the observation that substitution of active
Cdu1 in the cell cytoplasm removes the ubiquitin moieties from the
inclusion membrane, emphasising the importance of the active DUB
for keeping the inclusion free of ubiquitin (Figure 2c, d). In infected
cells, this process is restricted to the inclusion surface where the
deubiquitinase is anchored, since wild-type Cdu1 is not able to
deubiquitinate neighbouring mutant inclusions; the involvement of
soluble cytosolic factors can be excluded.
In contrast to our observations, LC3 has been shown to be rec-
ruited to C. trachomatis inclusions in other studies (Al-Younes et al.,
2004; Al-Younes et al., 2011). These authors used a polyclonal goat
antiserum (which is no longer available) which was directed against the
unmodified LC3 form. It is therefore possible that the modified active
LC3 preferably detected by the antibody used in this study is recruited
only to the ubiquitinated inclusion. Despite the strong ubiquitination
and the recruitment of autophagy receptors and effectors for phago-
phore formation to the inclusion in mutant infected cells, autophagy
appears not to be a major mechanism by which host cells restrict chla-
mydial infection. Interestingly, p62 and LC3 are increased during the
mid-phase of infection, when Cdu1 protein levels are also upregulated
(Fischer et al., 2017). Since we neither find ubiquitination nor the
recruitment of autophagy marker during the early phase of infection
before Cdu1 is expressed, the inclusion may either not be detected or
detection by the autophagic system may be actively prevented inde-
pendent of Cdu1. Moreover, inhibition of autophagy neither in early
phases by knock down of autophagy receptors (Figure 4d, e, f) nor in
late phases by Bafilomycin A1 inhibitor treatment (Figure 4b, c) could
rescue the growth defect of Ctr Tn-cdu1. Also inclusions of mutant
Chlamydia in HeLa cells that do not restrict growth and progeny infec-
tion are also decorated with autophagy markers (Figures 2a and 3a,
Figure S4a, b). Finally, no fusion with lysosomes was detected indicat-
ing that Ctr Tn-cdu1 is not degraded in autolysosomes (Figure 4a).
These findings therefore strongly suggest that the growth defect of Ctr
Tn-cdu1 is not due to clearance of infection by autophagy.
Our electron microscopic analyses revealed a reduced number of
EBs in Ctr Tn-cdu1 compared to wild-type bacteria (Figure 1c, d) in
line with impaired progeny infection of the mutant. We therefore pos-
tulate that redifferentiation of RBs to EBs is affected in Ctr Tn-cdu1.
Recently redifferentiation has been correlated to the RB size which is
reduced in every replication cycle until a certain threshold is reached
and EBs are formed (Lee et al., 2018). Analysis of bacterial RB size
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demonstrated that mutant bacteria are larger (Figure 1e) consistent
with a disturbed differentiation to EBs. Although the complete mecha-
nism of RB to EB transition is still unknown, the observed phenotype
could be explained by slowed growth and replication of Ctr Tn-cdu1.
Since bacteria depend on host metabolites for growth that they also
take from organelles like the Golgi apparatus, the structure of the
Golgi was further analysed. Indeed, Golgi membranes were less rec-
ruited to the Ctr Tn-cdu1 than the wild-type inclusions (Figure 5a, b).
Reduced availability of Golgi membranes at the chlamydial inclusion is
known to limit chlamydial growth (Heuer et al., 2009; Lipinski et al.,
2009). However, we could not observe a major difference in the
uptake of ceramide into the inclusion of wild-type Chlamydia and Ctr
Tn-cdu1. Furthermore, the growth defect of Ctr Tn-cdu1 was promi-
nent in primary Fimb cells, which neither display major Golgi fragmen-
tation upon infection with wild-type or mutant Chlamydia nor defects
in ceramide uptake into their inclusions. Recently, Ctr Tn-cdu1 was
suggested to avoid Golgi fragmentation (Pruneda et al., 2018). In con-
trast to their data we did see Golgi fragmentation in the cytoplasm of
Ctr Tn-cdu1 infected cells but reduced association of Golgi vesicles
with the inclusion. Recruitment of Golgi vesicles to the inclusion could
be rescued by expression of active Cdu1 (Figure 6a, b) consistent with
a central role of Cdu1 in this process. Although our data argue against
a central role of Golgi fragmentation or Golgi vesicle recruitment to
the inclusion as major reason for the growth defect of the Cdu1
mutant, Cdu1 appears to be a key factor required to keep the inclu-
sion surface susceptible for interaction with host vesicular trafficking
and possibly nutrient acquisition.
4 | EXPERIMENTAL PROCEDURES
4.1 | Cell lines and cultivation
HeLa 229 cells (ATCC Cat# CCL-2.1, RRID:CVCL_1276; tested negative
for mycoplasma contamination by polymerase chain reaction (PCR)), pri-
mary Fimb cells (primary cells of human fimbriae obtained from biopsies
of patients undergoing medically indicated surgery. According to the
hospitalisation contract patients agreed to scientific use of biopsies after
anonymization of samples; tested negative for mycoplasma contamina-
tion by PCR), U2OS cells expressing GFP (green fluorescent protein)-
LC3 or GFP-GABARAP (kind gift of Alexandra Stolz) and PentaKO or
Parental cells (kind gift of Michael Lazarou) were cultured in RPMI (Ros-
well Park Memorial Institute)-1640 medium (Gibco, Waltham, MA) sup-
plied with 10% fetal calf serum (FCS) (Paa, Germany). HUVEC (ATCC
Cat# CRL-1730; tested negative for mycoplasma contamination by PCR)
were grown in medium 200 supplemented with low serum growth sup-
plement (Thermo Fischer, Waltham, MA). Cells were cultivated by 37C
and 5% CO2. HeLa Cdu1-Flag inducible cell line was obtained by trans-
fection of FlpIn HeLa (kind gift of Ivan Dikic) cells with pcDNA5FRT/
Cdu1deltaTM-Flag plasmid and selection with hygromycin. The
pcDNA5FRT/Cdu1deltaTM-Flag plasmid was obtained by PCR using
the forward primer GATCGATATCATGTTATCTCCCACCAACTCA and
the reverse primer GATCGCGGCCGCTTACTTATCGTCGTCATCCTT
GTAATCTGCTTCAGGCCAAGAAAGCT and genomic DNA of Chlamydia
trachomatis L2 strain 434/Bu as template. Gene expression was initiated
by addition of 50 ng/ml AHT.
4.2 | siRNA knock-down in Fimb cells
For the siRNA knock-down Fimb cells were seeded in 12-well plates
and incubated over night at 37C and 5% CO2. For transfection siRNA
was diluted in 50 μl OptiMEM to a concentration of 300 nM and incu-
bated for 5 min. From the transfection reagent Lipofectamine
RNAiMAX 0.8 μl per well was mixed with 50 μl OptiMEM and incu-
bated at room temperature for 5 min. The siRNA mixture and the
transfection reagent was mixed and incubated at room temperature
for another 20 min. Supernatant was removed from the cells and over-
layed with 5% FCS RPMI 1640 medium. The siRNA Lipofectamine
mixture was added to the cells to a final concentration of siRNA of
30 nM. After 7 hr the medium was exchanged with fresh 20% FCS
RPMI 1640 medium. Two days later the transfected cells were
infected with Ctr Tn-cdu1 or CtrWT with an MOI of 0.3.
4.3 | Cultivation of Ctr and inhibitor treatment
For chlamydial infection cells were grown until a confluency of 70%
was reached. Medium was exchanged for RPMI-1640 containing 5%
FCS and chlamydial particles resembling a MOI of 1. Cells were incu-
bated at 35C and 5% CO2 until further needed. For inhibitor treat-
ment 10 nM Bafilomycin A1 (Thermo Fischer) or 2 μM MLN4924
was added to the infected cells 17 or 22 hpi respectively. For stock
preparation cells were scraped and lysed with glass beads 48 hpi.
Chlamydia were separated by centrifugation at 1000g for 10 min and
pelleted at 30 000g for 30 min both at 4C. After washing the bacte-
ria with 1× sucrose-phosphate-glutamic acid (SPG buffer (75 g/L
sucrose, 0.52 g/L KH2PO4, 1.22 g/L Na2HPO4, 0.72 g/L L-glutamic
acid, pH 7.4) Chlamydia were re-suspended in 1× SPG, aliquoted and
stored at −80C until needed. Bacteria were tested for mycoplasma
contamination by PCR and inclusion forming unit was determined.
4.4 | Infectivity assays
Fimb, HUVEC HeLa and PentaKO cells were seeded in two 12 well
microplates and grown to a confluency of 70%. Cells were infected
with Ctr WT or Ctr Tn-cdu1 with an MOI of 1 for HeLa and PentaKO
cells and an MOI of 0.3 for primary cells as described before. Primary
lysates were taken 24 hpi by adding 2× SDS lysis buffer (100 mM
Tris/HCl [pH 6.8], 20% glycerin, 4% SDS, 1.5% 2-mercaptoethanol,
0.2% bromphenolblue) to the cells. For progeny infection infected
cells were lysed with glass beads 48 hpi and an aliquot of the superna-
tant was used to infect a fresh 12 well plate seeded with fresh cells.
Lysates of progeny infection were taken 24 hpi as described. For anal-
ysis in immunoblot lysates were heated at 94C for 5 min.
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4.5 | Indirect immunofluorescence
Cells were grown on glass cover slides and infected as described above.
For inducible cell lines 50 ng/ml AHT was added 4 hr before harvest.
Cells were washed with phosphate-buffered saline (PBS) (Gibco) once
and fixed using 4% PFA/sucrose. After permeabilisation with 0.2% Trit-
onX 100 in PBS for 30 min, antigens were blocked with 2% FCS in PBS
for 1 hr. Primary antibodies were diluted as follows in 2% FCS in PBS:
anti-K48 (Merck #05-1,307, 1:500), anti-K63 (Merck #05–1,308,
1:100), anti-Ubi FK2 (Enzo #BML-PW8810-0500, 1:200), anti-cHSP60
(selfmade, 1:800), anti-Cdu1 (selfmade (Fischer et al., 2017), 1:300),
anti-p62 (santa cruz #sc-28,359, 1:1000), anti-LC3B (cell signalling
#2775, 1:50), anti-NBR1 (santa cruz #sc-130,380, 1:200), anti-NDP52
(santa cruz #sc-376,540, 1:200), anti-ATG12 (cell signalling #2010,
1:200), anti-Ankib1 (Thermo Fischer #PA5-54506, 1:200), anti-GM130
(BD #610823, 1:400), anti-Lamp1 (santa cruz #sc-18,821, 1:200). After
incubation with the primary antibody for 1 hr at room temperature,
remaining antibody was washed away and the secondary Cy3 or Cy5
coupled antibody (Dianova) was diluted 1:300 in 2% FCS in PBS and
incubated in the dark for 1 hr. Nucleic acid was stained with DAPI for
30 min.
4.6 | Ceramide uptake assay by live cell imaging
Cells were seeded in glass bottom dishes (ibidi, Gräfelfing, Germany)
and infected with Ctr WT and Ctr Tn-cdu1 for 24 hr. 1.5 μM SiR-DNA
dye (Spirochrome, Stein am Rhein, Switzerland) was added and incu-
bated for 1 hr. Cells were washed three times with PBS, before live
cell imaging media (RPMI 1640 (Gibco) + 25 mM N-2-hydro-
xyethylpiperazine-N-2-ethane sulfonic acid (HEPES) (Gibco)) was
added. Imaging was performed using a Leica TCS SP5 confocal micro-
scope with a 63× oil immersion objective connected with a pre-
warmed (37C) incubation chamber. 0.5 μM nitrobenzoxadiazole
(NBD)-C6-ceramide (Invitrogen, Waltham, Massachusetts, USA) was
added to the cells and images were acquired every minute using the
LAS software. Recorded pictures were processed with ImageJ.
4.7 | Immunoblotting
Lysates were loaded on a 10% SDS PAGE and transferred on a PVDF
membrane (Roche, Basel, Switzerland) using the semidry blotter (Thermo
Fischer). Membranes were blocked in 5% bovine serum albumin/tris-
buffered saline (BSA/TBS) containing 0.05% Tween20 (TBS-T) or 5%
milk/TBS-T for 1 hr and incubated with the primary antibody diluted in
5% BSA/TBS-T or 5% milk/TBS-T at 4C overnight. Primary antibodies
were diluted as follows: anti-LC3B (cell signalling #2775, 1:500), anti-
HSP60 (santa cruz #sc-57,840, 1:1000), anti-Actin (Sigma Aldrich
#A5441, 1:1000), anti-p62 (santa cruz #sc-28,359, 1:1000), anti-OmpA
(selfmade, 1:1000), anti-GAPDH (santa cruz, #sc-25,778, 1:1000). After
incubation membranes were washed three times with TBS-T and incu-
bated with the secondary antibody in 5% milk/TBS-T for 1 hr at room
temperature. The anti-mouse-horseradish peroxidase (HRP) (santa cruz,
#sc-516102) and anti-rabbit-HRP (Dianova, #111-035-144) secondary
antibodies were diluted 1:3000. Blots were washed as described and
analysed using ECL solutions and the Intas Chem HR 16–3200 reader.
Blots were quantified using ImageJ software.
4.8 | Transmission electron microscopy
Fimb cells were seeded on glass cover slides and infected with Ctr
Tn-cdu1 or Ctr WT with an MOI of 1. After 24 or 30 hr of infection
slides were washed once with PBS and fixed using 2.5% glutaralde-
hyde in 0.05 M Cacodylate buffer for 30 min at room temperature.
Cells were washed in Cacodylate buffer, incubated in 2%
OsO4/0.05 M Cacodylate buffer for 1 hr and in 0.5% Uranylacetat
overnight. Samples were dehydrated and embedded in EPON and
cut. Images were taken with the JEOL JEM-2100 microscope. For
analysis of RB diameter pictures were measured in ImageJ with five
inclusions per sample.
4.9 | Statistical analysis
Statistical analysis was performed using Excel. Statistical significance
between groups was determined using two-tailed Student's t test.
Data are shown as mean ± SE.
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